374
Views
10
CrossRef citations to date
0
Altmetric
Psoriasis

Improving psoriasis patients’ adherence to topical drugs: a systematic review

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 776-785 | Received 25 Apr 2019, Accepted 18 May 2019, Published online: 14 Jun 2019

References

  • Gudjonsson JE, Johnston A, Sigmundsdottir H, et al. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol. 2004;135:1–8.
  • Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76:377–390.
  • Jensen P, Ahlehoff O, Egeberg A, et al. Psoriasis and new-onset depression: a Danish Nationwide Cohort Study. Acta Derm Venereol. 2016;96:39–42.
  • Urquhart J. The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol. 2002;54:212–220.
  • Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011;270:147–157.
  • Ahlehoff O, Gislason GH, Lindhardsen J, et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS One. 2011;6:e18125.
  • Qureshi AA, Choi HK, Setty AR, et al. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009;145:379–382.
  • World Health Organization. Adherence to long-term therapies - Evidence for action [cited 2015 Oct 12]. Available from: http://appswhoint/iris/bitstream/10665/42682/1/9241545992pdf.
  • Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:Cd000011.
  • Balato N, Megna M, Di Costanzo L, et al. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol. 2013;168:201–205.
  • Alinia H, Moradi Tuchayi S, Smith JA, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Br J Dermatol. 2017;176:759–764.
  • Svendsen MT, Andersen F, Andersen KH, et al. A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial. Br J Dermatol. 2018;179:1062–1071.
  • Devine F, Edwards T, Feldman SR. Barriers to treatment: describing them from a different perspective. Patient Prefer Adher. 2018;12:129–133.
  • Svendsen MT, Andersen F, Hansen J, et al. Medical adherence to topical corticosteroid preparations prescribed for psoriasis: a systematic review. J Dermatol Treat. 2017;28:32–39.
  • Thorneloe RJ, Bundy C, Griffiths CEM, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168:20–31.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34.
  • Babineau J. Product review: covidence (systematic review software). J Can Health Libr Assoc. 2014;35:68–71.
  • Singh J. Critical appraisal skills programme. J Pharmacol Pharmacother. 2013;4:76.
  • Svendsen MT, Andersen K, Andersen F, et al. Psoriasis patients' experiences concerning medical adherence to treatment with topical corticosteroids. Psoriasis Targets Therapy. 2016;6:113–119.
  • Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
  • Caldarola G, De Simone C, Moretta G, et al. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients. J Dermatol Treat. 2017;28:722–725.
  • Reich K, Zschocke I, Bachelez H, et al. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP). Br J Dermatol. 2017;177:197–205.
  • de Korte J, Van Onselen J, Kownacki S, et al. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme. J Eur Acad Dermatol Venerol. 2005;19:35–41.
  • Ring L, Kettis-Lindblad A, Kjellgren KI, et al. Living with skin diseases and topical treatment: patients' and providers' perspectives and priorities. J Dermatol Treat. 2007;18:209–218.
  • Reich K, Mrowietz U, Karakasili E, et al. Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP). Arch Dermatol Res. 2014;306:667–676.
  • Uhlenhake EE, Kurkowski D, Feldman SR. Conversations on psoriasis what patients want and what physicians can provide: a qualitative look at patient and physician expectations. J Dermatol Treat. 2010;1:6–12.
  • Courtenay M, Carey N, Stenner K, et al. Patients' views of nurse prescribing: effects on care, concordance and medicine taking. Br J Dermatol. 2011;164:396–401.
  • Thorneloe RJ, Griffiths CE, Ashcroft DM, et al. The challenges of assessing patients' medication beliefs: a qualitative study. BMC Health Serv Res. 2017;17:119.
  • Thorneloe RJ, Bundy C, Griffiths CEM, et al. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. Br J Dermatol. 2017;176:667–676.
  • Courtenay M, Carey N. Nurse-led care in dermatology: a review of the literature. Br J Dermatol. 2006;154:1–6.
  • Carter P, Narasimhan B, Wang Q. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases. Int J Pharm. 2019;555:49–62.
  • Berrien VM, Salazar JC, Reynolds E, et al. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care Std. 2004;18:355–363.
  • Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension. A systems approach. Am J Hypertens. 2004;17:921–927.
  • Peveler R, George C, Kinmonth AL, et al. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ. 1999;319:612–615.
  • Ravn-Nielsen LV, Duckert M-L, Lund ML, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med. 2018;178:375–382.
  • Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181:566–577.
  • Oussedik E, Foy CG, Masicampo EJ, et al. Accountability: a missing construct in models of adherence behavior and in clinical practice. Patient Prefer Adher. 2017;11:1285–1294.
  • Baker JM, Grant RW, Gopalan A. A systematic review of care management interventions targeting multimorbidity and high care utilization. BMC Health Serv Res. 2018;18:65.
  • Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.